Phase 4 Diabetic Macular Oedema Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
Aflibercept for Diabetic Macular Oedema: Outcomes Using a Treat and Extend Protocol
Diabetic Macular Oedema
The Royal Adelaide Hospital50 enrolled2 locationsACTRN12619000963123
Completed
Phase 4
Intravitreal Aflibercept for the treatment of diabetic macular oedema
Diabetic Macular Oedema
Nitin Verma50 enrolled1 locationACTRN12618000428268
Not Yet Recruiting
Phase 4
The Influence of Serum and Aqueous Cytokine Concentrations on the Efficacy of Intravitreal Ranibizumab for the Treatment of Diabetic Macular Oedema
Diabetic Macular Oedema
The Centre for Eye Research Australia60 enrolled1 locationACTRN12618000079246
Completed
Phase 4
The Influence of Plasma and Aqueous Cytokine Concentrations on the Efficacy of Intravitreal Ranibizumab for the Treatment of Diabetic Macular Oedema
Diabetic Macular Oedema
The Centre for Eye Research Australia (The University of Melbourne)30 enrolled1 locationACTRN12615000830594
Recruiting
Phase 4
Intravitreal Aflibercept for the Treatment of Treatment Resistant Diabetic Macular Oedema
Diabetic Macular Oedema
Andrew Chang50 enrolled1 locationACTRN12614001307695